Latest news about Shyama Computronics and Services
Shyama Computronics and Services
3.46
+0.16(+4.85%)
Company Performance:
View Company Insights1D+4.85%
1M+15.33%
6M-29.39%
1Y-21.36%
5Y+41.80%
More news about Shyama Computronics and Services
13Nov 25
Shyama Computronics Reports Decline in Half-Year Profits for September 2025
Shyama Computronics and Services Limited released its unaudited standalone financial results for the half year ended September 30, 2025. The company's profit before tax decreased by 54.65% to Rs 7.90 lacs, down from Rs 17.42 lacs in the same period last year. However, cash and cash equivalents increased by 40.50% to Rs 1.70 lacs. The results were approved by the Board of Directors on November 12, 2025, and reviewed by statutory auditors AO Mittal Associates.
18Aug 25
Shyama Computronics Announces Major Leadership Overhaul and Key Appointments
Shyama Computronics and Services Limited (BSE: 531219) has announced significant leadership changes effective August 14, 2025. Mr. Rajib Singh has been appointed as the new Managing Director, replacing Mr. Samir Biswas. Mr. Dipak Kumar Das has been named the new Executive Director, succeeding Mr. Amit Paul. Both appointments are for five-year terms and subject to shareholder approval. The company has also appointed Mr. Sachin Pilania as Secretarial Auditor and Mr. Abhiset Basu as Internal Auditor. The board approved unaudited financial results for Q2 2025 and scheduled the 29th AGM for September 15, 2025, to be held via video conference.
14Aug 25
Shyama Computronics Announces Major Leadership Changes and Approves Q1 FY2026 Results
Shyama Computronics and Services Limited (BSE: 531219) has announced major leadership changes and approved Q1 FY2025-26 financial results. Mr. Rajib Singh and Mr. Dipak Kumar Das have been appointed as Managing Director and Executive Director respectively for five-year terms, replacing Mr. Samir Biswas and Mr. Amit Paul who have resigned. The company also appointed Mr. Sachin Pilania as Secretarial Auditor and Mr. Abhiset Basu as Internal Auditor. The Board approved unaudited Q1 results and scheduled the 29th AGM for September 15, 2025, via video conferencing.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Dr Reddys Laboratories
Zydus Life Science
Lupin
Mankind Pharma
Aurobindo Pharma
Laurus Labs
1,841.50
(+0.04%)
6,793.00
(+0.59%)
4,537.60
(+1.92%)
1,420.00
(+0.18%)
1,318.30
(-0.72%)
1,087.20
(+0.76%)
2,275.20
(+0.41%)
2,428.50
(+0.20%)
1,430.00
(-2.14%)
1,381.90
(+0.58%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
